OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/13/2026
Back to search
Official data from USPTO
NATMEDICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
08/13/2026
Trademark type
Combined
Nice classes
5
Filing date
05/30/2024
Registration date
01/13/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/13/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
COLEMAN, CIMMERIAN
Law office
N60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a design of a plant with a curved green stem that has small green branches extending from it. Alongside the stem, there are multiple red dots arranged in a cluster resembling berries. The design is enclosed within a red square. Below the design is the stylized wording "NATMEDICS" appearing in the color green. The background of the mark is in the color white.
Holders and representatives
Holders
Natmedics GmbH
Representatives
Thomas J. Vande Sande Hall & Vande Sande LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritional supplements; Mineral dietary supplements; Food supplements in liquid form; Herbal supplements; Plant-based antineoplastic preparations for the slowing of tumor growth and metastasis and strengthening of the immune system; Natural dietary supplements for treating claustrophobia; Pharmaceuticals and natural remediesnamely pharmaceutical preparations and natural remedy preparations for the treatment of neurocognitive disorders and age-related diseases; Probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; Allergy medication; Biological preparations for medical purposes for the treatment of neurocognitive disorders and age-related diseases; Mixed biological preparations for medical purposes for the treatment of neurocognitive disorders and age-related diseases; Biochemical preparations for medical use for the treatment of neurocognitive disorders and age-related diseases; Biological adjuvants for medical purposes; Medicines for the treatment of neurocognitive disorders and age-related diseases in the form of dragees; Tonicsnamely medicines for the treatment of neurocognitive disorders and age-related diseases; Medicines for the treatment of neurocognitive disorders and age-related diseases; Medicines for human purposes for the treatment of neurocognitive disorders and age-related diseases; Nutritional supplements made of starch adapted for medical use; Zinc dietary supplements; Dietary supplemental drinks; Nutraceuticals for use as a dietary supplement; Dietary supplements for human beings; Food supplements for sportsmen; Dietary supplements in powder form; Health-aid food supplements containing ginseng; Medicinal creams for protection of the skin; Creams for dermatological use; Barrier lotions for protection against poisonous plants; Anti-cancer preparations of plant origin; Plant extractsother than essential oilsfor pharmaceutical purposes.
Publications
History of USPTO decisions and trademark events.
25 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/06/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/27/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/26/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/19/2026
FIMP
FINAL DISPOSITION PROCESSED
07/19/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/13/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/13/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/13/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/25/2025
PUBO
PUBLISHED FOR OPPOSITION
11/25/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/07/2025
RFNT
REFUSAL PROCESSED BY IB
05/04/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/11/2025
RFRR
REFUSAL PROCESSED BY MPU
04/11/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/06/2025
CNRT
NON-FINAL ACTION WRITTEN
03/05/2025
DOCK
ASSIGNED TO EXAMINER
03/01/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/28/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/27/2025
Continuous trademark protection
Get notified about every new filing that threatens NATMEDICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.